Pilates and diaphragmatic breathing added to moderate cycling for people with high blood pressure
Official title: Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Cycling Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Patients With Hypertension
Run by Foundation University Islamabad · NCT07529834 · Data updated 2026-11-12
This trial will test whether adding Pilates and diaphragmatic breathing to moderate-intensity cycling helps adults with hypertension lower blood pressure and improve lung function and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 55 Years |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Foundation University Islamabad Academic / other |
| Locations | 1 site (Islamabad) |
| Status | Recruiting |
| Started | January 12, 2026 |
| Main results expected | May 15, 2026 |
| Study ends | May 15, 2026 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT07529834 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 20–55 years old with stage 1–2 hypertension on stable antihypertensive therapy who can safely perform moderate exercise and provide informed consent.
✕Probably not a fit
People with stage 3 or crisis-level hypertension, major orthopedic problems, or other conditions that prevent safe participation in exercise are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, three-arm parallel trial will enroll 45 adults aged 20–55 with stage 1–2 hypertension who have been on stable antihypertensive medication for at least three months. Participants will be randomized into one of three groups of 15 to receive moderate-intensity continuous cycling (55–70% maximal heart rate, RPE 11–13) alone or combined with Pilates breathing or combined with diaphragmatic breathing. Outcomes include systolic and diastolic blood pressure, chest expansion, pulmonary function, and quality of life measured with validated tools, with blood pressure measured by sphygmomanometer. Participants are screened for exercise readiness using PAR-Q+ and are referred from local clinics or hospitals.
Why it matters
Potential benefit: If successful, adding targeted breathing techniques to moderate cycling could reduce blood pressure and improve breathing and daily functioning for people with hypertension.
How similar studies have gone: Previous studies pairing aerobic exercise with controlled breathing techniques have reported modest improvements in blood pressure and respiratory outcomes, though evidence for these exact combined protocols is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Medically diagnosed patients having Stage 1 hypertension(SBP;140-159 mmHg,DBP:90-99mmHg) and Stage 2 -hypertension(SBP:≥160mmHg,DBP:≥100mmHg) according to JNC 8 Guidelines, referred by a medical specialist or GP or cardiologist from FFH or clinical setups or Hospitals of Rawalpindi/Islambad * Patients who are on antihypertensive medications for at least 3 months before study. * Age ranging from 20-55 years * Both male and female patients. * Patients who are willing to participate in exercise regime and are able to -provide informed consent, have not been a part of any exercise regime from the last 6 months and well tolerated for exercise after being screened through PAR-Q+ Exclusion Criteria: * Patients with Stage 3 hypertension (SBP: ≥180 mmHg or DBP: ≥110 mmHg) and above hypertension according to JNC 8 Guidelines or Hypertensive Crisis etc. * Patients with any severe knee or other orthopedic conditions that can limit exercise performance * Patients with uncontrolled hypertension * History of any abdominal, orthopedic or spinal surgery that could interfere with core or breathing exercise * Neurological or psychiatric disorders * Uncontrolled cardiovascular conditions such as arrhythmias or recent myocardial infarction * Pregnant women
Where it's running
-
Foundation University, Islamabad
Islamabad, Pakistan Recruiting
Study contacts
- Study coordinator: Saba Rehman, MSPT-CPT
- Email: sabarehman278@gmail.com
- Phone: 03295200871
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.